SARS-CoV-2: Infections, Treatment, and Development of Vaccines—2nd Edition
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "COVID-19 Vaccines and Vaccination".
Deadline for manuscript submissions: 28 February 2026 | Viewed by 17
Special Issue Editors
Interests: exosome; extracelular vesicule; intracelllar comminication; immune tolerance; vaccine
Special Issues, Collections and Topics in MDPI journals
Interests: small RNA; nuclear protein transport; cell death mechanism
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Due to the emergence of new variants, SARS-CoV-2 continues to pose challenges. Therapeutic drugs and vaccines have been developed for SARS-CoV-2, and new vaccines are currently being evaluated. With the emergence of variants, it is essential that we consider the accompanying changes in infectivity, transmissibility, antigenicity, and pathogenicity, as well as the efficacy of current vaccines. Recent studies have shown that neutralizing antibodies against the spike (S) protein play a crucial role in the protective effects induced by vaccines. Additionally, other immune responses beyond neutralizing antibodies, such as cell-mediated and innate immunity, may contribute to vaccines' overall preventive effect. These immune responses may influence vaccine robustness and continued vaccine efficacy in disease prevention. This Special Issue will highlight the latest research on the efficacy, development, molecular mechanisms, and prevention of SARS-CoV-2 infection.
We welcome both research articles and reviews.
We look forward to receiving your contributions.
Dr. Yasunari Matsuzaka
Dr. Ryu Yashiro
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- SARS-CoV-2
- vaccines
- COVID-19
- diagnosis
- treatment
- antibodies
- monoclonal antibodies
- recombinant protein
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
